Android Apple

Y-mAbs Therapeutics, Inc. (YMAB) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$8.31

south_east -$0.27 (-3.09%)
Day's range
$8
Day's range
$8.47

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/11/2024 BMO Capital Etzer Darout $24.00 $15.06   59.36%
06/28/2024 Truist Financial Nicole Germino $21.00 $12.33   70.32%
05/10/2024 H.C. Wainwright Robert Burns $22.00 $12.87   70.94%
04/05/2024 BMO Capital Etzer Darout $26.00 $14.56   78.57%
05/10/2023 Wedbush YMAB)to Outperform $13.00 $9.90   31.38%

Y-mAbs Therapeutics, Inc. FAQ's

What analysts cover Y-mAbs Therapeutics, Inc.?

Y-mAbs Therapeutics, Inc. has been rated by research analysts at BMO Capital, Truist Financial, H.C. Wainwright, Wedbush in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.